Reports Library Publication
Insight Consumer Healthcare Europe June / July 2025
1st August 2025 by CHC Insight
- Analgesics Haleon among the most active players
- Stada Health Report 2025 Focus on health aspirations, barriers and trust
- PAGB Self-Care Census Insights into self-care trends, attitudes and more
- Analgesics Non-cores Panadol Duo rolled out across region
- Innovation Round-up Centrum multivitamin gets cellular ageing sub-range
- News Review MAT Q1 2025 update from DB6 shows global growth of +3.2%
Order this report
Why buy this report?
"Analgesics is in focus in our June / July issue. Growth picked up vs the previous reporting period as higher incidence of cold & flu drove demand in some markets. It was an interesting year for NPD, with several paracetamol + ibuprofen combination launches across the region, Germany’s first dexibuprofen 200mg and aspirin 1g, and more high-strength additions in Poland (although Polpharma launched and then requested the reverse switch of the country’s first metamizole 1g product). We also share two highly valuable studies – from Stada and the UK’s industry association, PAGB – highlighting healthcare attitudes, behaviours and experiences, plus our usual round-up and analysis of the latest product innovation and industry news."
Nicholas Hall